Alterations of platelet, coagulation, and fibrinolysis markers in patients with acute ischemic stroke

Seminars in Thrombosis and Hemostasis

Volumn 23, Issue 6, 1997, Pages 535-541

  Uchiyama, Shinichiro ^a   Yamazaki, Masako ^a   Hara, Yukiko ^a   Iwata, Makoto ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Antithrombotic therapy; Cerebral infarction; Coagulation; Fibrinolysis; Platelets

Indexed keywords

ALPHA 2 ANTIPLASMIN; D DIMER; FIBRINOPEPTIDE A; PLASMIN; THROMBIN ANTITHROMBIN COMPLEX;

BLOOD CLOTTING; BRAIN INFARCTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE LIFESPAN;

EID: 0031427238     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996132     Document Type: Conference Paper

References (25)

1. Special report from the National Institute of Neurological Disorders and Stroke: Classification of cerebrovascular diseases III. Stroke 21:637-676, 1990.
2. Mohr JP, RL Sacco: Classification of ischemic strokes. In Barnett HJM, JP Mohr, BM Stein, FM Yatsu (eds): Stroke: Pathophysiology, Diagnosis, and Management. 2nd ed. Churchill Livingston, New York, 1992, pp 271-283.
3. Uchiyama S, M Yamazaki, M Iwata, S Maruyama: Diagnosis of intracardiac thrombi by various imaging techniques and platelet, coagulation and fibrinolysis activation in patients with cardioembolic stroke. Clin Neurol (Tokyo) 36:429-435, 1996.
4. Uchiyama S, M Takeuchi, M Osawa, I Kobayashi, S Maruyama, M Aosaki, K Hirosawa: Platelet function tests in thrombotic cerebrovascular disorders. Stroke 14:511-517, 1983.
5. Uchiyama S, R Sone, Y Shibagaki, I Kobayashi, M Yamazaki, S Maruyama: Multipathways leading to platelet aggregation and platelet release reaction in patients with cerebral ischemia, Clin Neurol (Tokyo) 28:1065-1071, 1988.
6. Uchiyama S, R Sone, T Nagayama, Y Shibagaki, I Kobayashi, S Maruyama, K Kusakabe: Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia. Stroke 20:1643-1647, 1989.
7. Uchiyama S, M Yamazaki, S Maruyama, M Handa, Y Ikeda, M Fukuyama, I Itagaki: Shear-induced platelet aggregation and its inhibition by antiplatelet agents in cerebral ischemia. Clin Hemorheol 13:623-636, 1993.
8. Uchiyama S, M Yamazaki, S Maruyama, M Handa, Y Ikeda, M Fukuyama, I Itagaki: Shear-induced platelet aggregation in cerebral ischemia. Stroke 25:1547-1551, 1994.
9. Uchiyama S, M Mochizuki, H Tci, I Kobayashi, S Maruyama: Evaluation of antithrombotic therapy by platelet-labeling with indium-111 tropolone in ischemic stroke. Neurol Therapeutics (Tokyo) 8:57-62, 1991.
10. Uchiyama S, M Yamazaki, M Iwata: Cerebral ischemia and platelet activation. Adv Neurol Sci (Tokyo) 40:666-678, 1996.
11. Warkentin TE, MJ Powling, RM Hardisty: Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: A micromethod for the detection of platelet activation. Br J Haematol 76:387-394, 1990.
12. Lindahl TL, R Festin, A Larsson: Studies of fibrinogen binding to platelets by flow cytometry: An improved method for studies of platelet activation. Thromb Haemostas 68:221-225, 1992.
13. Auls KA, HM Rinder, JG Mitcell, CS Rinder, CT Rambrew, RS Hillman: Correlated measurement of platelet release and aggregation in whole blood. Cytometry 10:448-455, 1989.
14. Konstantopoulos K, JC Grotta, C Sills, KK Wu, JD Hellums: Shear-induced platelet aggregation in normal subjects and stroke patients. Thromb Haemostas 74:1329-1334, 1995.
15. Yamazaki M, S Uchiyama, S Maruyama: Alterations of haemostatic markers in various subtypes and phases of stroke. Blood Coag Fibrinolysis 4:707-712, 1993.
16. Dewanjee MK, A Sham, SA Rao, P Didisheim: Indium-111 tropolone, a new high affinity plalelet label: Preparation and evaluation of labeling parameters. J Nucl Med 22:981-987, 1981.
17. Ikeda Y, M Handa, K Kawano, I Itagaki, K Sakai, ZM Ruggeri: The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87:1234-1240, 1991.
18. Moake JL, NA Turner, NA Stathopoulos, L Nalasco, JD Hellums: Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistent to aspirin. Blood 71:1366-1374, 1988.
19. Moake JL, NA Turner, NA Stathopoulos, TD Giorgio, JD Hellums: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear-induced platelet aggregation. J Clin Invest 78:1456-1461, 1986.
20. Peterson DM, NA Stathopoulos, LH Giorgio, JD Hellums, JL Moake: Shear-induced platelet aggregation requires von Willebrand factor and platelet glycoproteins Ib and IIb/IIIa. Blood 69:625-628, 1987.
21. Markus HS, MJ Harrison: Microembolic signal detection using ultrasound. Stroke 26: 1517-1519, 1995.
22. Cerebral Embolism Task Force: Cardiogenic brain embolism. Arch Neurol 43:71-84, 1986.
23. Hacke W, W Kaste, C Fieschi, C Toni, E Lesaffre, R von Kummer et al, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017-1025, 1995.
24. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587, 1995.
25. Adams Jr HP, TG Brott, AJ Furlan, CR Gomez, J Grotta, CM Helgason, T Kwiatkovski, PD Lyden, JR Marler, J Torner, W Feinherg, M Mayberg, W Thies: Guideline for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 27:1711-1718, 1996.